Allan C J, Skett P
Department of Pharmacology, University of Glasgow.
J Endocrinol. 1988 Jul;118(1):19-23. doi: 10.1677/joe.0.1180019.
Hepatocytes, isolated from adult male rats and maintained in serum- and hormone-free medium, were pretreated with phorbol esters known to activate protein kinase C (4 beta-phorbol-12-myristate-13-acetate) and to be inactive in this respect (4 alpha-phorbol and its 12,13-didecanoate ester). Subsequently the cells were assayed for steroid-metabolizing capacity using androst-4-ene-3,17-dione as substrate. The active phorbol ester was seen to inhibit steroid metabolism markedly after 1 h whereas the inactive derivatives did not show this effect. The endogenous activator of protein kinase C (diacylglycerol) was also seen to inhibit steroid metabolism in a manner similar to the 4 beta-phorbol ester. Hepatic steroid metabolism is, thus, inhibited by activation of protein kinase C and this may be one of the mechanisms by which the regulatory hormones (e.g. growth hormone) affect steroid metabolism in the liver.
从成年雄性大鼠分离出肝细胞,并将其置于无血清和无激素的培养基中培养,先用已知可激活蛋白激酶C的佛波酯(4β-佛波醇-12-肉豆蔻酸酯-13-乙酸酯)以及在这方面无活性的佛波酯(4α-佛波醇及其12,13-二十二烷酸酯)进行预处理。随后,以雄甾-4-烯-3,17-二酮为底物,对细胞的类固醇代谢能力进行测定。1小时后,活性佛波酯可显著抑制类固醇代谢,而无活性衍生物则无此作用。蛋白激酶C的内源性激活剂(二酰基甘油)也以类似于4β-佛波酯的方式抑制类固醇代谢。因此,蛋白激酶C的激活可抑制肝脏类固醇代谢,这可能是调节激素(如生长激素)影响肝脏类固醇代谢的机制之一。